gvtcx

NHS Framework Agreement for Branded Medicines - National Tender

NHS England Published 28 Jun 2022 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£3,186,167,792
Statuscomplete
Category (CPV) 33600000
Deadline9 Dec 2021
Procedureopen
OCIDocds-h6vhtk-02f3ac

Awards (87)

This procurement was awarded to 86 suppliers. Values shown are per-award; the notice total is £3,186,167,792.

SupplierValueDateStatus
Abbvie Ltd shared · · active
Accord-UK Ltd shared · · active
Aguettant Ltd shared · · active
Alliance Pharmaceuticals Limited shared · · active
AOP Orphan Ltd shared · · active
Aspen Pharmacare UK Limited shared · · active
Aspire Pharma Limited shared · · active
AstraZeneca shared · · active
Aventis Pharma ltd t/a Sanofi shared · · active
Baxter Healthcare Ltd shared · · active
Bayer Ltd shared · · active
B. Braun Medical Limited shared · · active
Biofrontera Pharma GmbH shared · · active
Cambridge Healthcare Supplies Ltd shared · · active
Cenote Pharma Limited shared · · active
Chiesi Limited shared · · active
Cipla shared · · active
Clinigen Healthcare Limited shared · · active
Colonis Pharma Ltd shared · · active
Crescent Pharma Ltd shared · · active
CST Pharma Limited shared · · active
Day Lewis Medical Ltd shared · · active
Dexcel Pharma Ltd shared · · active
Dr Falk Pharma UK Ltd shared · · active
Drugsrus Ltd shared · · active
Eisai Ltd shared · · active
Eli Lilly and Company Ltd shared · · active
ennogen healthcare ltd shared · · active
EVER Pharma UK Ltd. shared · · active
Ferndale Pharmaceuticals Ltd shared · · active
Ferring Pharmaceuticals Ltd shared · · active
FLYNN PHARMA LTD shared · · active
Focus Pharmaceuticals Ltd shared · · active
Fontus Health Ltd shared · · active
Fresenius Kabi Limited shared · · active
Galen Limited shared · · active
GlaxoSmithKline UK Limited shared · · active
Glenmark Pharmaceuticals Europe Limited shared · · active
Grunenthal shared · · active
Intrapharm Laboratories Ltd shared · · active
Janssen-Cilag Ltd shared · · active
Karo Pharma UK Ltd shared · · active
Kent Pharma Ltd shared · · active
Kyowa Kirin Ltd shared · · active
LogixX Pharma Ltd shared · · active
Lupin Healthcare (UK) Limited shared · · active
Martindale Pharma shared · · active
Merck Sharpe and Dohme (UK) Limited shared · · active
Mercury Pharmaceuticals Limited shared · · active
mibe Pharma UK Ltd shared · · active
Morningside Pharmaeuticals shared · · active
Mylan shared · · active
Napp Pharmaceuticals Ltd shared · · active
Necessity Supplies Limited shared · · active
Neon Healthcare Ltd shared · · active
Norgine Pharmaceuticals Limited shared · · active
Novo Nordisk shared · · active
Opella Healthcare UK LTD shared · · active
Oralieve UK Ltd shared · · active
Organon Pharmaceuticals UK Ltd shared · · active
ORPHALAN UK LTD shared · · active
PARI shared · · active
Pfizer Ltd shared · · active
Pharmacosmos UK Ltd shared · · active
Ranbaxy UK shared · · active
Rayner Surgical Group Ltd shared · · active
Reckitt Benckiser shared · · active
Recordati Rare Diseases UK Ltd shared · · active
Roche Products Ltd shared · · active
Roma Pharmaceuticals Limited shared · · active
Rosemont Pharmaceuticals Limited shared · · active
Sandoz Ltd shared · · active
Selective Supplies Ltd. shared · · active
Stirling Anglian Pharmaceuticals Ltd shared · · active
Strides Pharma Uk LTD shared · · active
Takeda UK Ltd shared · · active
Teva UK Limited shared · · active
Thea Pharmaceuticals Limited shared · · active
Thornton and Ross Ltd shared · · active
Tillomed Laboratories ltd shared · · active
Tillotts Pharma UK Ltd shared · · active
Torrent Pharma UK Ltd shared · · active
Typharm Ltd shared · · active
Univar Solutions shared · · active
Wockhardt UK Limited shared · · active
Zentiva Pharma UK Ltd shared · · active
not named · · unsuccessful

description

NHS Framework Agreement for Branded Medicines - National Tender <br/>Offer reference number: CM/PHR/21/5643<br/>NHS Framework for Branded Medicines - National Tender – 01 May 2022 to 30 April 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

7 notices published against this procurement.

PublishedTypeRegimeNotice
19 Oct 2021 Contract notice (F02) Earlier regulations 026078-2021
4 Nov 2021 Contract notice (F02) Earlier regulations 027710-2021
17 Nov 2021 Contract award notice (F03) Earlier regulations 028721-2021
9 Dec 2021 Corrigendum (F14) Earlier regulations 030670-2021
9 Dec 2021 Tender (tender) · 1062bff3-4962-44d2-90dc-27f0dd1553d6-492872
28 Jun 2022 Contract award notice (F03) Earlier regulations 017595-2022
19 Jun 2023 Tender (tender) · 929dddfe-8869-4dff-8126-d9810c6c4f18-654779

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.